News
Über uns
Julia
Sanfilippo-Syndrom
Kontakt
Fotos/Medien
Hilf uns!

Monat: Januar 2026

Home / 2026 / Januar

Beitrag

News von Ultragenyx

Ultragenyx reicht erneut Zulassungsantrag für Biologika für UX111 AAV Gentherapie zur Behandlung des Sanfilippo-Syndroms Typ A (MPS IIIA) bei der US-amerikanischen FDA ein.

Hope For JuliaDeutsch30. Januar 202627. Oktober 2026

HOPE FOR JULIA
Ursina Schmid &
Mario Rosario Raciti
Im Rosgarten 2
7205 Zizers

info@hopeforjulia.ch

Social Media

Facebook
Instagram

Links

Inhaltliche Verantwortung: Hope For Julia * * * Umsetzung: Driftwood | The Content Company * * * Impressum * * * Datenschutzerklärung

Um den Betrieb dieser Webseite zu ermöglichen, setzen wir Cookies ein. Wenn Sie auf unserer Webseite bleiben, akzeptieren Sie diese Cookies.

Akzeptieren

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Immer aktiviert

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT